BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 20/08/2026

FDA Renews Endocrinologic and Metabolic Drugs Advisory Committee for 2 Years

The FDA has renewed the Endocrinologic and Metabolic Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on August 27, 2028.

Source: Federal Register — Health and Human ServicesOpen original release →